News | EP Lab | November 15, 2021

FDA Clears vMap Technology to Identify Arrhythmia Hot Spots Using Only ECG

Noninvasive technology does not require vests, CT or MRI imaging or invasive catheter mapping


November 15, 2021 — Vektor Medical Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its computational ECG mapping system, vMap. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or unstable arrhythmias anywhere in the heart—including all four chambers, the septal wall, and the outflow tracts—in less than three minutes using only ECG data, to improve outcomes in ablation procedures. Following clearance, the vMap system will be commercially available to sites across the U.S.

vMap has demonstrated success in identifying arrhythmia sources for a wide variety of arrhythmias, including atrial fibrillation. The easy-to-use system takes less than three minutes for a clinician to input case information, download and markup an ECG in the system, and receive a three-dimensional, interactive arrhythmia hot spot map visualizing the inside and outside of the heart. vMap can be used as a non-invasive standalone tool or as a complement to traditional invasive electro-anatomical mapping systems in planning and procedural settings. 

“Traditional arrhythmia mapping techniques are labor-and time-intensive, and physicians are only able to achieve complete success in a limited number of ablation procedures due to the lack of information on arrhythmia source locations. To shorten procedure times and improve ablation success, electrophysiologists need to be able to visualize arrhythmia hot spots in the heart quickly and accurately,” said Amir Schricker, M.D., MS, medical director of cardiac electrophysiology at Mills Peninsula Medical Center, a Sutter Health hospital. “Our clinical experience with vMap has been incredibly positive. Using non-invasive ECG data, the system is extremely simple and fast to use, and quickly provides a hot spot map so we know where to target our efforts without having to navigate the whole heart or order additional imaging.”

“Cardiac arrhythmias impact millions of people across the globe, increasing the risk of serious health-related issues, such as stroke, heart failure, and even death. Yet, today’s therapies have significant issues - drug therapy can have severe side effects and non-targeted ablation has disappointingly low success rates,” said Vektor Medical CEO Mike Monko. “With vMap we are changing how electrophysiologists think about mapping. By providing a hot spot map in only minutes based on non-invasive ECG data, physicians can create a more effective ablation plan and spend less time finding target locations. Our goal is to increase first-pass success rates, lower risk, and decrease the current cost burden of ablation on the healthcare system.”

San Diego-based Vektor Medical Inc. is the developer of the world’s first technology to rapidly map arrhythmias anywhere in the heart using only 12-lead ECG data. This data is analyzed using proprietary computational modeling to create actionable 2D and 3D maps of potential arrhythmia sources. The company’s smart, simple, and non-invasive cardiac arrhythmia mapping platform aims to improve first-pass ablation success, lower risks from invasive mapping and long fluoro exposure, and reduce procedure times1, all of which are expected to reduce healthcare costs associated with ablation.

For more information: www.vektormedical.com

 

Reference:

1 Ho, G. et al. Simplified workflow to improve the precision of non-invasive radio-ablation of ventricular tachycardia storm. Presented at AHA 2020.

Related Content

News | ECG

September 1, 2021 — University of South Australia researchers have designed a computer vision system that can ...

Home September 01, 2021
Home
News | ECG

June 18, 2021 — You might be older ― or younger ― than you think. A new study found that differences between a person's ...

Home June 18, 2021
Home
News | ECG

February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG home ...

Home February 16, 2021
Home
News | ECG

February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated ...

Home February 02, 2021
Home
Feature | ECG | By Dave Fornell, Editor

Here are a few trends to watch for in electrocardiogram (ECG, or if you prefer the original German EKG) systems. The ...

Home January 20, 2021
Home
Feature | ECG

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

Home March 11, 2020
Home
Feature | ECG

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...

Home February 19, 2020
Home
News | ECG

January 22, 2020 – Bittium is exhibiting solutions for cardiology at Arab Health 2019, Jan. 27-30 in Dubai, United Arab ...

Home January 22, 2020
Home
News | ECG

December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today ...

Home December 12, 2019
Home
Technology | ECG

May 13, 2019 — AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making ...

Home May 13, 2019
Home
Subscribe Now